Molecular modeling and site-specific mutagenesis of the histamine-binding site of the histamine H4 receptor

Molecular Pharmacology

Volumn 62, Issue 1, 2002, Pages 38-47

  Shin, Niu ^a   Coates, Elizabeth ^a   Murgolo, Nicholas J ^a   Morse, Kelley L ^a   Bayne, Marvin ^a   Strader, Catherine D ^a   Monsma Jr , Frederick J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; HISTAMINE; HISTAMINE H4 RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; CALCIUM MOBILIZATION; DRUG BINDING SITE; GENETIC TRANSFECTION; IMMUNE RESPONSE; MOLECULAR MODEL; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SITE DIRECTED MUTAGENESIS;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ASPARAGINE; BINDING SITES; CALCIUM; CELLS, CULTURED; HISTAMINE; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PHENYLALANINE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, HISTAMINE; SEQUENCE HOMOLOGY, AMINO ACID; SERINE; TYROSINE;

EID: 0036089526     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.62.1.38     Document Type: Article

References (43)

1. Integrated methods for the construction of three dimensional models and computational probing of structure-function relations in G-protein coupled receptors
2. 1B-adrenergic receptor is a key residue coupling TM helical movements to G-protein activation
3. 1B-adrenergic receptor signal-inactivating point mutation
4. Phe310 in transmembrane VI of the α1B-adrenergic receptor is a key switch residue involved in activation and catecholamine ring aromatic bonding
5. Contribution of conserved serine residues to the interactions of ligands with dopamine D2 receptors
6. Conformational changes in rhodopsin
7. Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin
8. Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: Conserved aspartic acids play important roles in receptor function
9. 2 receptor
10. 2 receptor
11. 2 adrenergic receptor
12. 1A receptor and the role of residue F331 in signal transduction
13. 1A receptor: A site-directed mutation study
14. The unique nature of the serine interactions for α1-adrenergic receptor agonist binding and activation
15. Constitutive activation of the β2 adrenergic receptor alters the orientation of its sixth membrane-spanning segment
16. Agonist-induced conformational changes at the cytoplasmic side of transmembrane segment 6 in the β2 adrenergic receptor mapped by site-selective fluorescent labeling
17. 1-receptor agonists
18. Accurate modeling of protein conformation by automatic segment matching
19. 3 receptor: Role of two amino acids in the third transmembrane domain
20. Specific tryptophan UV-absorbance changes are probes of the transition of rhodopsin to its active state
21. 4) expressed in bone marrow
22. 3 receptor reveals distinct species pharmacological profiles
23. 3 receptor
24. Molecular characterization of the melanin-concentrating hormone/receptor complex: Identification of critical residues involved in binding and activation
25. Exploration of the ligand binding site of the human 5-HT(4) receptor by site-directed mutagenesis and molecular modeling
26. Cloning and characterization of a novel human histamine receptor
27. Discovery of a novel member of the histamine receptor family
28. 1 receptor
29. Molecular cloning and characterization of novel type of histamine receptor preferentially expressed in leukocytes
30. 194
31. Crystal structure of rhodopsin: A G protein-coupled receptor
32. Serine mutations in transmembrane V of the dopamine D1 receptor affect ligand interactions and receptor activation
33. 2a serotonin receptors revealed by mutation and molecular modeling of conserved residues in transmembrane region 5
34. Identification of two serine residues involved in agonist activation of the β-adrenergic receptor
35. Structural basis of β-adrenergic receptor function
36. Conserved aspartic acid residues 79 and 113 of the β-adrenergic receptor have different roles in receptor function
37. Identification of residues required for ligand binding to the β-adrenergic receptor
38. Molecular architecture of G-protein coupled receptors
39. Site-directed mutagenesis of α2a-adrenergic receptors: Identification of amino acids involved in ligand binding and receptor activation by agonists
40. Tautomerism and the receptor activation of histamine: A mechanistic model
41. Role of conserved threonine and tyrosine residues in acetylcholine binding and muscarinic receptor activation
42. 1 receptor
43. Cloning, expression and pharmacological characterization of a novel human histamine receptor